Karen A Cullen1, Shannon Stokley2, Lauri E Markowitz3. 1. Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Ga. Electronic address: kcullen@cdc.gov. 2. Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Ga. 3. Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Ga.
Abstract
OBJECTIVE: The Advisory Committee on Immunization Practices (ACIP) has recommended routine human papillomavirus (HPV) vaccination at age 11 or 12 years for girls since 2006 and for boys since 2011. We sought to describe adolescent HPV vaccination coverage, doses administered from 2009 to 2012, and age at first vaccination by sex. METHODS: Aggregate data were analyzed from 8 Immunization Information System sentinel sites on HPV vaccinations in children and adolescents aged 11 to 12 years, 13 to 15 years, and 16 to 18 years. Vaccination coverage by age group was reported for 2009 to 2012, and weekly doses administered were determined. Age at first HPV vaccination was calculated for girls in 2007 and 2011 and for boys in 2011. RESULTS: This analysis included data on 2.9 million adolescents aged 11 to 18 years. There were small increases in coverage for girls, with receipt of ≥1 dose of HPV vaccine reaching 27.1% of ages 11 to 12, 47.9% of ages 13 to 15, and 57.1% of ages 16 to 18 by December 31, 2012. Uptake of ≥1 dose in boys reached ∼18% for all age groups. Doses administered showed seasonal variation, with highest uptake before back to school among girls and steady increases in boys after the 2009 ACIP recommendation for permissive use. Doses administered to boys surpassed those administered to girls by September 2012. Among vaccinated girls, more received vaccine at the recommended age of 11 to 12 years in 2011 (74.2%) compared to 2007 (9.9%). In 2011, 27.3% of vaccinated boys received their first dose at age 11 to 12 years. CONCLUSIONS: HPV vaccination coverage increased among adolescents between 2009 and 2012. However, increases among girls were small, and coverage for boys and girls remained below target levels. Published by Elsevier Inc.
OBJECTIVE: The Advisory Committee on Immunization Practices (ACIP) has recommended routine human papillomavirus (HPV) vaccination at age 11 or 12 years for girls since 2006 and for boys since 2011. We sought to describe adolescent HPV vaccination coverage, doses administered from 2009 to 2012, and age at first vaccination by sex. METHODS: Aggregate data were analyzed from 8 Immunization Information System sentinel sites on HPV vaccinations in children and adolescents aged 11 to 12 years, 13 to 15 years, and 16 to 18 years. Vaccination coverage by age group was reported for 2009 to 2012, and weekly doses administered were determined. Age at first HPV vaccination was calculated for girls in 2007 and 2011 and for boys in 2011. RESULTS: This analysis included data on 2.9 million adolescents aged 11 to 18 years. There were small increases in coverage for girls, with receipt of ≥1 dose of HPV vaccine reaching 27.1% of ages 11 to 12, 47.9% of ages 13 to 15, and 57.1% of ages 16 to 18 by December 31, 2012. Uptake of ≥1 dose in boys reached ∼18% for all age groups. Doses administered showed seasonal variation, with highest uptake before back to school among girls and steady increases in boys after the 2009 ACIP recommendation for permissive use. Doses administered to boys surpassed those administered to girls by September 2012. Among vaccinated girls, more received vaccine at the recommended age of 11 to 12 years in 2011 (74.2%) compared to 2007 (9.9%). In 2011, 27.3% of vaccinated boys received their first dose at age 11 to 12 years. CONCLUSIONS:HPV vaccination coverage increased among adolescents between 2009 and 2012. However, increases among girls were small, and coverage for boys and girls remained below target levels. Published by Elsevier Inc.
Entities:
Keywords:
adolescent; human papillomavirus vaccine; immunization
Authors: Summer Sherburne Hawkins; Krisztina Horvath; Jessica Cohen; Lydia E Pace; Christopher F Baum Journal: Cancer Causes Control Date: 2021-04-17 Impact factor: 2.506
Authors: L Aubree Shay; Richard L Street; Austin S Baldwin; Emily G Marks; Simon Craddock Lee; Robin T Higashi; Celette Sugg Skinner; Sobha Fuller; Donna Persaud; Jasmin A Tiro Journal: Patient Educ Couns Date: 2016-06-25
Authors: Susan T Vadaparampil; Teri L Malo; Steven K Sutton; Karla N Ali; Jessica A Kahn; Alix Casler; Daniel Salmon; Barbara Walkosz; Richard G Roetzheim; Gregory D Zimet; Anna R Giuliano Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-08-02 Impact factor: 4.254
Authors: Ashley Daily; Erin D Kennedy; Leslie A Fierro; Jenica Huddleston Reed; Michael Greene; Warren W Williams; Heather V Evanson; Regina Cox; Patrick Koeppl; Ken Gerlach Journal: Vaccine Date: 2016-10-11 Impact factor: 3.641
Authors: Jonathan M Raviotta; Mary Patricia Nowalk; Chyongchiou Jeng Lin; Hsin-Hui Huang; Richard K Zimmerman Journal: Am J Mens Health Date: 2014-11-11
Authors: Tanya L Kowalczyk Mullins; Gregory D Zimet; Susan L Rosenthal; Charlene Morrow; Lili Ding; Bin Huang; Jessica A Kahn Journal: Vaccine Date: 2016-06-10 Impact factor: 3.641
Authors: Jennifer L Moss; Paul L Reiter; Barbara K Rimer; Kurt M Ribisl; Noel T Brewer Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-12-16 Impact factor: 4.254